{"slideshow_credits": null, "snippet": "The company said on Tuesday that growing demand for expensive specialty drugs helped increase revenue from its pharmacy benefits management business nearly 22 percent in the quarter, to $23.9 billion.", "abstract": "CVS reports fourth-quarter earnings of $1.32 billion, or $1.14 a share, up 4 percent from $1.27 billion, or $1.05 a share, in year-earlier period; results match Wall Street expectations.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/02/11/business/cvs-earnings-increase-4-despite-end-of-tobacco-sales.html", "lead_paragraph": "The company said on Tuesday that growing demand for expensive specialty drugs helped increase revenue from its pharmacy benefits management business nearly 22 percent in the quarter, to $23.9 billion.", "headline": {"main": "CVS Earnings Increase 4%, Despite End of Tobacco Sales", "content_kicker": "Business Briefing", "print_headline": "Cvs Earnings Increase 4%, Despite End of Tobacco Sales"}, "_id": "54daa6d438f0d86139007531", "word_count": "129", "multimedia": [], "pub_date": "2015-02-11T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "CVS Caremark Corporation", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Company Reports", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Smoking and Tobacco", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}